Nick Spittal | Chief Operations Officer
Velocity Clinical Research
Nick Spittal is COO of Velocity Clinical Research, the largest global organization of fully-owned clinical research sites. With over two decades in a broad range of roles at global CROs, Nick brings innovative ideas and technology into site operations to fulfill Velocity’s vision of making clinical research accessible to all. Nick’s team is leading sites to deliver faster startup, predictable enrollment, and the highest quality data at scale for clinical Sponsors. Velocity Clinical Research is the 2024 winner of the Vaccine Industry Excellence award for best Clinical Trial Company and a 2025 founding member of the Association for Multisite Reseach Corporations in 2025 (https://amrc.org).
Appearances:
Main Congress Day 2 - 23rd April @ 09:55
Panel: Mitigating the growing risk of duplicate and professional participants in vaccine clinical trials
- li>
- What is the impact?
- Why is this a particular problem in Vaccine trials?
- What are the trends we are seeing surrounding this issue?
- How can this risk be mitigated or prevented?
Main Congress Day 3 - 24th April @ 09:55
Learnings from a 50,000 patient-activated vaccine community
HealthMatch & Velocity Clinical Research created a 50,000 patient activated vaccine community in 2024, months in advance of any specific study launch. The community was educated, nurtured and insights gathered to ultimately shape recruitment strategy and outcomes across multiple vaccine studies at the end of 2024. The speakers will share learnings from the project including performance around randomizations and patient education and discuss how this methodology can be applied successfully to other therapeutic areas.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events